About: Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.22 (-0.71%)
CRBP NASDAQ Corbus Pharmaceuticals Holding
Corbus Pharmaceuticals Holding share price
Atividade de preço de CRBP
Último preço
$ 4,220
Variação (24h)
-0,03 USD (0,71%)
Volume
1.48M
Volume (média 4 sem.)
-
Abertura
$ 4,25
Variação do dia
$ 4,10 - $ 4,34
Fechamento anterior
$ 4,25
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
CRBP price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals